Prognostic factors of overall survival in head and neck cancer: Post-hoc exploratory results from the SPINNAKER trial—A phase III randomized clinical trial of pemetrexed plus cisplatin versus cisplatin monotherapy

Autor:	Susan G. Urba, Andrew Koustenis, J. Gatz, Patrick Peterson, Anwar Hossain, Katherine B. Winfree, Wei Shen
Rok vydání:	2011
Předmět:	Cisplatin Oncology Cancer Research medicine.medical_specialty Post hoc SpiNNaker business.industry Head and neck cancer medicine.disease law.invention Pemetrexed Randomized controlled trial law Internal medicine Overall survival Medicine business Survival rate medicine.drug
Zdroj:	Journal of Clinical Oncology. 29:5531-5531
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2011.29.15_suppl.5531
Popis:	5531 Background: Recurrent and metastatic head and neck cancers (HNC) are generally incurable, with ~20% 1-year survival rate. The objective of this analysis was to examine the prognostic factors (...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::98ef7ee413201d725d12e20e61540714 https://doi.org/10.1200/jco.2011.29.15_suppl.5531 Zobrazit plný text záznamu